网站大量收购独家精品文档,联系QQ:2885784924

NO ET-1 in patients with obstructive sleep apnea-hypopnea syndrome in Progress.doc

NO ET-1 in patients with obstructive sleep apnea-hypopnea syndrome in Progress.doc

  1. 1、本文档共16页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
NO ET-1 in patients with obstructive sleep apnea-hypopnea syndrome in Progress

 PAGE \* MERGEFORMAT 16 NO ET-1 in patients with obstructive sleep apnea-hypopnea syndrome in Progress [Keywords:] Obstructive sleep apnea-hypopnea syndrome NO ET-1 Obstructive sleep apnea-hypopnea syndrome (Obstructive sleep apnea-hypopnea syndrome, OSAHS) is a common sleep breathing disorders, it is because during sleep in patients with recurrent partial or complete upper airway obstruction caused by apnea and hypoxia hyperlipidemia, sleep structure, disorder, common in the elderly, but now there are getting younger and younger, young adults view physical health appears severely damaged. Clinically, in order to habitual snoring, daytime sleepiness and merging different degrees of organ dysfunction as the main performance [1]. Modern medicine in many disorders that OSAHS has become the source of the disease, and the impact has been seen as major cause of death. OSAHS patients during sleep apnea caused by repeated episodes of hypoxemia, awakening to reflect and sharp fluctuations in intrathoracic negative pressure through the neuro-hormonal factors such as long-term effects caused by endothelial dysfunction. NO, ET-1 is a release of vascular endothelial small molecules, both the maintenance of vasomotor function of the interaction. Study confirmed that, OSAHS is essential hypertension (EH) is an independent risk factor for disease [2]. Repeated sleep apnea can cause high blood pressure, high blood pressure and hypoxia-related. Clinical treatment is aimed at alleviating symptoms of snoring and apnea, hypoxemia lift will help to control and gradually restore the body in patients with metabolic functions. 1 OSAHS treatment status Obstructive sleep apnea-hypopnea syndrome (OSAHS) is the most common clinical disease of sleep-disordered breathing (SDB) is one, OSAHS with snoring, repeated apnea (hypopnea) and the consequent awakening (arousal), lead to inadequate sleep at night, and varying degrees of daytime sleepiness such as the main symptom, and can lead to

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档